BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 3753551)

  • 1. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
    Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
    Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
    Kooistra KL; Rodriguez M; Powis G
    Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization.
    Caplan J; Pradilla G; Hdeib A; Tyler BM; Legnani FG; Bagley CA; Brem H; Jallo G
    Neurosurgery; 2006 Jul; 59(1):193-200; discussion 193-200. PubMed ID: 16823316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
    Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
    Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrastructural study of the growth pattern in an experimental meningeal gliomatosis model].
    Narumi S; Murakami M; Murakami T; Obonai C; Nanami T; Kikuchi Y; Kirikae M; Kanaya H
    No Shinkei Geka; 1988 Oct; 16(11):1261-6. PubMed ID: 3211274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Growth activity of meningeal carcinomatosis--immunohistochemical study using anti-BrdU monoclonal antibody].
    Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Huang TY; Kuroda R; Mogami H
    No To Shinkei; 1988 Feb; 40(2):127-31. PubMed ID: 3370164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal gene therapy for malignant leptomeningeal neoplasia.
    Ram Z; Walbridge S; Oshiro EM; Viola JJ; Chiang Y; Mueller SN; Blaese RM; Oldfield EH
    Cancer Res; 1994 Apr; 54(8):2141-5. PubMed ID: 8174120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal model of intramedullary spinal cord glioma using human glioblastoma multiforme neurospheres.
    Hsu W; Siu IM; Pradilla G; Gokaslan ZL; Jallo GI; Gallia GL
    J Neurosurg Spine; 2012 Mar; 16(3):315-9. PubMed ID: 22195609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model.
    Lefranc F; Cool V; Velu T; Brotchi J; De Witte O
    Int J Oncol; 2002 May; 20(5):1077-85. PubMed ID: 11956607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal 5-[125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases.
    Sahu SK; Wen PY; Foulon CF; Nagel JS; Black PM; Adelstein SJ; Kassis AI
    J Nucl Med; 1997 Mar; 38(3):386-90. PubMed ID: 9074525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
    Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meningeal gliomatosis model in nude mice].
    Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Yoshida T; Hayakawa T; Tsuda N; Mogami H
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2600-5. PubMed ID: 3740860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meningeal gliomatosis: development of experimental models].
    Yoshida T; Ushio Y; Hayakawa T; Arita N; Yamada K; Mogami H
    No Shinkei Geka; 1984 Sep; 12(10):1141-8. PubMed ID: 6504251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis.
    Fuchs HE; Archer GE; Colvin OM; Bigner SH; Schuster JM; Fuller GN; Muhlbaier LH; Schold SC; Friedman HS; Bigner DD
    Cancer Res; 1990 Mar; 50(6):1954-9. PubMed ID: 2306744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
    Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
    Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro study on intrathecal application of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant tumor].
    Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
    No Shinkei Geka; 1998 Sep; 26(9):787-94. PubMed ID: 9757455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
    Izumoto S; Arita N; Ushio Y; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Oku Y; Mogami H; Komeshima N
    Gan To Kagaku Ryoho; 1988 May; 15(5):1765-9. PubMed ID: 3369870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone.
    Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K
    Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.